Based on a review of its unaudited financial results to 31 May 2016, continuation of recent trading performance and no material change in market conditions in June, the Company has determined it appropriate to further revise its full year outlook upward.
The a2 Milk Company Limited is pleased to announce its admission to the S&P/ASX 200 Index effective after the close of trading on 17 June 2016.
Results of a human clinical trial show that A1 protein in cows’ milk may trigger symptoms of lactose intolerance. a2 Milk™, naturally free from A1 protein, potential solution for millions.
The New Zealand Government today awarded a $NZ1.15 million High-Value Nutrition research grant to AgResearch Limited to undertake research to validate the benefits of A2 beta casein protein contained in milk-based products on digestive function
The a2 Milk Company Limited is a dual listed on the NZX and ASX.
Visit our Investor Centre for up-to-date information about our company and our performance.